FDA Drug Recalls

Recalls / Class II

Class IID-0160-2019

Product

HCG Lyopholized 1200 IU Injectable, Pharm D Solutions, Houston, Texas ---- NDC 69699-1743-12

Affected lot / code info
Lot: 04092018:58 Discard by: 10/6/2018; 06072018:03 Discard by: 12/4/2018; 05292018:86 Discard by: 11/25/2018; 07192018:64 Discard by: 1/15/2019; 08302018:30 Discard by: 2/26/2019

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
Pharm D Solutions, LLC
Notification channel
Press Release
Type
Voluntary: Firm initiated
Address
1304 S Loop W, N/A, Houston, Texas 77054-4010

Distribution

Quantity
881 vials
Distribution pattern
Nationwide

Timeline

Recall initiated
2018-09-10
FDA classified
2018-11-01
Posted by FDA
2018-11-07
Terminated
2021-02-05
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0160-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls